Dr David Cutter
Clinical Research Fellow (CTSU) and Consultant Clinical Oncologist (Oxford Cancer Centre)
David Cutter studied medicine at the University of Cambridge (1994-2000) and trained in Oncology at the Oxford Cancer Centre. In 2008 he joined CTSU to study for a DPhil on the late cardiovascular effects of cancer treatments. In 2013 he was appointed as a Consultant Clinical Oncologist and continues to work within CTSU upon a programme of work investigating the benefits and risks of cancer treatments.
Clinical intensity-modulated proton therapy for Hodgkin lymphoma: which patients benefit the most?
Ntentas G. et al, (2019), Pract Radiat Oncol
Cardiac structure doses in women irradiated for breast cancer in the past and their use in epidemiological studies.
Duane FK. et al, (2019), Pract Radiat Oncol
Modeling Radiation Therapy-Related Risk of Heart Failure in Survivors of Pediatric Malignancy: Early Results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Group
Bates JE. et al, (2018), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102, S53 - S53
Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.
Taylor C. et al, (2018), J Clin Oncol, 36, 2288 - 2296
Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods
Ntentas G. et al, (2018), RADIOTHERAPY AND ONCOLOGY, 127, S1091 - S1092